ArticleOncotarget2016

The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma.

Claudia Pivonello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.